Pathway, an innovative data company developing live AI systems, has successfully raised $10 million in a seed funding round led by TQ Ventures, with participation from Kadmos and Id4 Menlo Park, California. This investment will drive the company’s mission to create AI systems capable of complex reasoning, combining cutting-edge technology with dynamic, evidence-based data.
Founded by Adrian Kosowski (CSO) and Jan Chorowski (CTO), both of whom previously collaborated with Geoffrey Hinton, the renowned “Godfather of AI” and a recent Nobel laureate in physics, Pathway aims to redefine how AI supports industries like healthcare. The company’s platform is designed to compile clinical practice guidelines from millions of evidence-based sources, enabling healthcare professionals to quickly and accurately access medical information.
Pathway’s unique offering includes infrastructure components that power live AI systems, dynamically integrating structured and unstructured data sources. This enables real-time decision-making based on continuously updated knowledge. This is particularly crucial in regulated industries where data is complex and requires precise and timely management.
The company’s growing customer base includes high-profile clients in industries with stringent data needs, such as NATO and La Poste, signaling the increasing demand for Pathway’s live AI solutions.
The funding will be used to accelerate Pathway’s development, ensuring that its platform continues to advance and provide value in sectors that rely on complex, real-time information processing.